ArticleInternational journal of molecular sciences2021

IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses.

Taylor A Harper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.